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BACKGROUND: Autism spectrum disorder (ASD) is an early-onset neurodevelopmental disorder with 1 in 68 children
prevalence. The key symptoms of ASD include social deficits, verbal and non-verbal communication deficits, and
restricted, repetitive patterns of behavior, interests, or activities. For unknown reasons, gastrointestinal symptoms
are related to ASD. The aim of the current paper is to review the available literature on dietary interventions in
children with ASD and provide up-to-date evidence.
METHODS: Searches in online databases, using the search terms’ dietary intervention, “autism spectrum disorders,”
and “autism” were conducted. The search targeted publications ranging from 2010 to 2020.
RESULTS: Twenty-six studies with different study designs which evaluated the effectiveness of specific dietary
interventions in children with ASD were included in our review. Several dietary interventions were of popular practice
in the management of children with ASD, including elimination (gluten-/casein-free diet and oligoantigenic diet),
modification (modified ketogenic diet), supplementation (minerals, vitamins, omega 3, and omega 6), and exclusion
(food additives). Studies showed different results with varying degrees of evidence. Overall, data were inadequate
to make accurate conclusions.
CONCLUSION: There is little evidence to support the use of dietary interventions for children with ASD. Additional
high-quality studies and further research are, therefore, needed.

Background
Autism spectrum disorder (ASD) is a
neurodevelopmental disorder that starts early in
childhood and is characterized by impairment in
reciprocal social communication and a tendency to
engage in a repetitive, stereotyped pattern of behavior,
interest, and activities [1]. The prevalence of ASD is
increasing worldwide, with boys more affected than
girls [2]. Recent studies estimated the prevalence of ASD
to be 1 in 68 children, with as many as 50% of children
showing behavioral regression around the age of
three [3]. The etiological factors are heterogeneous and
include genetic, epigenetic, and environmental factors;
however, its pathogenesis remains unknown [1]. About
5%–15% of individuals with ASD have either a single
gene disorder or chromosomal abnormality, and despite
the link between ASD and some genetic disorders, for
example, Fragile X syndrome and tuberous sclerosis,
no specific gene has been identified [4]. Genetic factors
are modulated by prenatal (e.g., exposed to antiepileptic
drugs and advanced paternal age) [5], perinatal (e.g.,
infections during pregnancy and maternal autoimmune
diseases) [6], and postnatal (e.g., prematurity and

obstetrical complications) [7] environmental factors in
some patients.
It is apparent that, for unknown reasons,
systemic clusters of symptoms are related to ASD,
including gastrointestinal [GI] problems, mitochondrial
dysfunction, and “allergic” symptoms, especially food
intolerance and eczema [8]. Parents of children with
ASD reported selective eating behavior in 58–67% of
the cases [9].
With no known cure for ASD, most treatments
have focused on improving the social, behavioral, and
communicative symptoms. As a general principle,
individuals with ASD require a comprehensive
management approach that is individualized according
to the child’s age and specific needs. The variation and
complexity of the presentation of children with ASD
can lead to difficulties in determining the most effective
interventions. At present, no medication treatments
are approved for the core symptoms of ASD; however,
some medications are approved by the Food Drug
Administration for the associated irritability and
aggression in children with ASD (i.e., risperidone and
aripiprazole, [10]). A comprehensive multidisciplinary
approach is recommended in the management of
ASD in the practical clinical guidelines [11]. One of
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the suggested elements of this approach is a dietary
intervention, an available approach used with and
without clinical supervision to alleviate GI and behavioral
symptoms. Some authors have suggested that support
for the nutritional and metabolic problems may be
ameliorated by increasing nutrient intake, which may
reduce the symptoms and comorbidities associated
with ASD [12].
Accordingly, some therapists in clinical
practice advise parents of children with ASD to follow
certain dietary interventions, to improve some core or
GI-related symptoms of ASD [13]. Several studies in
the literature have investigated the effects of dietary
interventions on ASD symptoms [14], [15], [16]. It
would be beneficial for both clinicians and parents of
children with ASD to receive evidence-based dietary
interventions that address food preference and food
selectivity in children with ASD.
The purpose of this paper is to provide up-todate evidence for dietary interventions in children with
ASD, including gluten-free and casein-free, ketogenic,
and specific carbohydrate diets, as well as probiotics,
polyunsaturated fatty acids, and dietary supplements
(Vitamins A, C, B6, and B12; magnesium; and folate) by
reviewing the available data. Focusing on medications
is out of the scope of this paper.

Methodology
Methods
The researchers independently conducted
a systematic search and review in two databases:
PubMed and Google Scholar, using the search key terms
“dietary intervention,” “autism spectrum disorders,”
and “autism.” The reference lists of identified articles
were also assessed to identify additional relevant
articles. The search also included psychiatry textbooks
and published and unpublished treatment guidelines.
The targeted publications ranged from 2010 to 2020.
A total of 26 articles were included and reviewed.
The analyzed data were categorized into clinical and
nutrition groups. Finally, the results were combined to
ascertain information about the correlation between
diet, dietary interventions, and ASD.
We developed inclusion criteria in consultation
with an expert panel of clinicians, dietitians, and
researchers. We included studies published in English
of any design that examined relationships between diet,
dietary interventions, and ASD.
The studies reviewed in this article used
standardized criteria from DSM-IV, DSM-V, or ICD-10
(American Psychiatric Association 1994, 2013; World
Health Organization 1993) to diagnose individuals with
ASD.
Open Access Maced J Med Sci. 2021 Mar 18; 9(F):88-94.

Results
In some individuals with ASD, early diagnosis
of nutritional deficiencies and metabolic disorders and
implementing appropriate therapeutic interventions
have significantly improved cognitive abilities and
behavioral difficulties [17], [18], [19]. Despite the
scarcity of sufficient scientific and clinical evidence
that supports the role of dietary interventions as
part of ASD management [20]; it is still commonly
recommended as a part of ASD management by some
health providers [21]. These dietary interventions are
based on either addition or elimination of certain food
elements and nutrients associated with GI symptoms in
children with ASD, such as inflammatory bowel disease,
food intolerance, and allergies. Children with ASD tend
to have food selectivity in comparison to other kids
without neurodevelopmental disorders. Factors that
may affect food selectivity in children with ASD include
GI problems and “allergic” symptoms, especially food
intolerance and eczema. Other factors, as reviewed
by Whiteley et al., include food texture (69%), food
appearance (58%), food taste (45%), smell (36%), and
food temperature (22%) [22]. This food selectivity can
result in nutritional imbalance which may eventually be
detrimental on brain function [23]. Hence, the problem
of food selectivity needs to be carefully addressed
through appropriate dietary interventions.
Types of dietary interventions
In an effort to identify the role of dietary
intervention in the management of ASD, researchers
have investigated the GI tract (GIT)-related ASD
symptoms. They found that protein digestive
capacity may be impaired in some children with ASD,
contributing to the abnormal immune activation and GI
symptoms observed in these populations [24]. Studies
have revealed decreased activity of several digestive
enzymes as well as GI symptoms (loose stools and/
or gaseousness), in children with ASD [25]. Other
researchers have reported elevated levels of urinary
peptides of dietary origin in children with ASD, providing
further evidence that this population experiences
impaired protein digestion, coupled with increased
intestinal permeability [26]. Based on the results of
the above-mentioned studies, researchers have found
promising evidence to support the role of dietary
interventions in children with ASD [24].
Gluten-free/Casein-free (GFCF) diets
Despite little evidence to support positive
effects, GFCF diets are considered the most common
types of dietary interventions used in ASD [27]. The
focus on GFCF diets, as an important dietary approach
for children with ASD, originates from the evidence of
89
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comorbid GIT problems related to consumption of foods
containing casein and gluten [28], [29]. However, the
explanation for increased GI problems in ASD remains
unclear. One possible explanation that received attention
could be related to increased intestinal permeability,
the so-called leaky gut [30], [31]. Based on the “opioid
excess theory,” digestion of gluten and casein results
in the production of peptides with an opioid activity that
can enter the bloodstream when the gut permeability is
high [32], [33]. Therefore, these neuroactive peptides
would, in turn, bind to opioid receptors and are ultimately
speculated to affect processes in the central nervous
system [34].
The use of a gluten-free diet necessitates the
examination of the effects of removing all the food
items containing gluten (the protein found in starch
foods such as wheat, oats, barley, or rye). This dietary
intervention is based on the exclusion of these food
items from the diet and replaced by special glutenfree food items. Another dietary approach used for
individuals with ASD, is the gluten-free diet combined
with a casein-free diet. Casein is a peptide commonly
found in milk and other dairy products. Consequently,
a casein-free diet involves eliminating the intake of
milk and dairy products. The main idea is to follow this
elimination for a certain period and then reintroduce
the products containing gluten/casein gradually to
examine its contribution to ASD symptoms [35].
Studies that evaluated gluten-/casein-free diets
reported some improvements in communication and
challenging behaviors; however, the evidence was
inconclusive [36], [37], [38].
Modified ketogenic, gluten-free diet
regimen
The ketogenic diet (KD) is a low-carbohydrate,
moderate protein, high-fat diet that has emerged as
a potential dietary intervention for ASD [39]. Some
studies have supported the effectiveness of a modified
ketogenic, gluten-free diet regimen with supplemental
medium-chain triglyceride (MCT) as an effective dietary
intervention for children with ASD. These studies
support the notion that the KD alters neural cellular
metabolism by utilizing ketone bodies as an alternative
fuel for the brain [40].
Lee et al. reported moderate and substantial
improvement in Autism Diagnostic Observation Scale-2
(approximately 20–50% improvement in the social
affect domain) following the use of modified KD/GF/
MCT for 3 months in children with ASD [39]. Accordingly,
the authors have concluded that their results could
support the suggestion that the KD components may
offer an effective and safe treatment for children with
ASD, especially for their social impairment. On the
contrary, other researchers did not observe a significant
correlation between beta-hydroxybutyrate “BHB” levels
(a ketone synthesized in the liver from fatty acids when
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the supply of glucose is too low for the body’s energetic
needs, such as during periods of prolonged exercise,
starvation, or absence of dietary sources) and the
degree of improvement in ASD symptoms [41].
Role of vitamins and minerals in ASD
Some health-care professionals consider
vitamins, mineral supplements, and other nonpharmacological interventions to play a role in improving
some ASD symptoms. There is some evidence that
vitamins and mineral supplementations support the
body’s basic physiologic processes and impact various
metabolic and nutritional abnormalities (e.g., sulfation,
methylation, glutathione redox imbalances, oxidative
stress, and mitochondrial dysfunction). Nevertheless,
there is no substantial evidence to support the efficacy
of vitamin and mineral supplementations in improving
children with ASD symptoms [42]. A recent study
investigated the effect of Vitamin A deficiency on
children with ASD and concluded Vitamin A deficiency
exacerbates the core symptoms in children with ASD,
especially when there are comorbid GI symptoms [43].
Vitamin C may have an effect on children with ASD,
based on its vital role in brain neurons development,
functional maturation, and antioxidant effect [44].
Hatice et al. studied the relationship between
Vitamin D and its receptors, homocysteine, Vitamins
B6, B12, and folate levels in 60 children with ASD and
45 children as the control group. The study observed
that the total score of the Childhood Autism Rating
Scale was positively linked to low serum levels of
Vitamins D, B6, B12, folate, and Vitamin D receptors
and high homocysteine levels [45]. This implies that
these nutrients may be involved in the etiopathogenesis
of ASD [46]. These findings may be of fundamental
importance to care providers of children with ASD.
ω-3 and ω-6 fatty acid supplementation
Researchers have also investigated the
effect of supplementation with n–3 (ω-3) including
docosahexaenoic acid and n–6 (ω-6) fatty acids
including γ-linolenic acid on children born preterm
who display early signs of ASD. They found that they
helped promote cognitive development [47], [48]. They
observed that children assigned to treatment with n–3
(ω-3) and n–6 (ω-6) fatty acids supplementation exhibited
a significant reduction in ASD symptoms as per the
Brief Infant-Toddler Social and Emotional Assessment
scale, in comparison to the placebo group. However,
the number of studies investigating the effectiveness of
omega 3 supplements on alleviating the core symptoms
of ASD was limited, and the overall effects were small,
precluding definitive conclusions. Future large-scale
randomized clinical trials are needed to confirm or refute
the efficacy of omega 3 and 6 [49], [50].
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Food additives exclusion diet
Feingold, an American pediatrician and
allergist, was the first to suggest that allergy to food
additives, such as artificial flavors and colors, as well
as naturally occurring salicylates, could contribute
to symptoms of neurodevelopmental disorders [51].
It is believed that people with ASD cannot tolerate a
range of additives, including aspartame, monosodium
glutamate, and artificial colors (e.g., sunset yellow
{E110}, tartrazine {E102}, carmoisine {E122}, Ponceau
4R {E124}), and sodium benzoate {E211}), evidenced
by adverse effects on their behavior. While the
avoidance of particular additives is very common, there
has been little good quality research on the effect of
food additives on patients with ASD [52].
Oligoantigenic diet in ASD
Another dietary approach that has received
considerable attention in children with ASD is the
oligoantigenic diets. The basis for this diet is to mainly
focus on eliminating suspected high allergenic food
products rather than eliminating artificial colors, flavors,
and preservatives precisely [35]. The oligoantigenic diet
intervention, also known as the restricted elimination diet
or hypoallergenic diet, follows a process that focuses on
eliminating foods that are often highly allergenic, such
as cow’s milk, cheese, eggs, chocolate, and nuts. The
oligoantigenic diet approach involves an elimination
phase, typically 2–5 weeks, where specific food items
would be completely excluded. The food items allowed
in the elimination phase could consist of only a few
hypoallergenic foods such as rice, turkey, lettuce, pears,
and water [53]. The patient would then be monitored for
a substantial decrease in ASD symptoms, which would
indicate “food sensitivity.” This would be followed by the
reintroduction phase, which involves the introduction
of specific food items and observation for triggering of
symptoms. In total, the assessment period could take up
to 18 months. Therefore, the elimination/reintroduction
of diet serves as a “diagnostic” tool for identifying the
specific food items responsible for the physical and/or
behavioral disorders in children with ASD.
Jose et al. reviewed the most relevant available
data for the dietary and nutritional interventions in
children diagnosed with ASD. Table 1 summarizes the
level of evidence to each dietary intervention that has
been addressed in the current review.

acid supplementations, food additives, exclusion diet,
and the oligoantigenic diet. Despite the variation in the
results of the studies conducted on dietary interventions
and supplements in children with ASD, the interventions
long-term effects are not well addressed in the research.
The Center for Disease Control and Prevention stresses
that “while remedies that work for one child may not
work for another, dietary changes or supplements are
a worthwhile option to explore [55].” Many families
of children with ASD use dietary interventions and
supplements, even without clear evidence on safety and
efficacy. Therefore, a comprehensive multidisciplinary
team is required and should include families of autistic
children in the management plan with particular advice
on the risk and benefits of using dietary intervention
and supplements. Child and adolescents’ psychiatrists
as well as other mental health-care professionals must
receive training in nutritional principles for patients with
ASD and other neurodevelopmental disorders.
Table 1: Levels of evidence of complementary and alternative
treatments in children diagnosed with ASD*
Treatment

Evidence

Comments

Gluten‑free
diet/casein‑free
diet

Single‑blind trials suggested
a potential benefit in
5–7‑year‑old children with GI
symptoms
A double‑blind trial does not
show benefit
Several systematic reviews
Studies report benefits but
with many methodological
problems

Need for studies to clarify
the utility
Risk of nutritional
involvement
Supervision by a
specialist in nutrition
Absence of high‑quality
evidence that shows
effectiveness on the
core and associated
symptoms ASD
Need for more studies
based on promising
effects in other
populations
Significant
methodological problems

Omega‑3 fatty
acids

Vitamins/
minerals/
supplements
Vitamin A
Vitamin C

Vitamin D
Vitamins
B6 and
magnesium

Vitamin B12

A double‑blind,
placebo‑controlled
randomized trials
Theories
No evidence of effectiveness
Two double‑blind,
placebo‑controlled trials
Circumstantial
evidence‑based treatment
2005 Cochrane review: No
recommendation
Update 2010: Same
conclusion
A small open pilot study
No additional studies since
2008 review
Twelve‑week double‑blind,
placebo‑controlled study
Improvement in a subgroup

Significant possibility
of harm
Some preliminary
evidence
Non‑significant toxicity
Theories
Methodological problems
Poor quality of the
studies
No recommendation
Potential neurotoxicity of
B6 and/or magnesium
Need for more studies to
define responders’ group

Grade of
evidence
B

C

C

D
B

D
D

C+

A: More than 1 high‑quality study with consistent results or an extensive multicenter study. B: A high‑quality
study or several studies with mild limitations. C: A study with important limitations. D: No evidence/theories/
multiple studies with very serious limitations. *Adapted from Levy SE, Hyman SL [54]. ASD: Autism
spectrum disorder.

Discussion

Conclusion

This review summarizes different dietary
interventions for ASD, including gluten-free and caseinfree, KDs, vitamins and minerals, omega 3 and 6 fatty

Despite many research efforts investigating
the effects of dietary interventions in ASD, our review
shows no consensus exists to support specific dietary

Open Access Maced J Med Sci. 2021 Mar 18; 9(F):88-94.
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interventions and supplementations in this patient
population. More high-quality, longitudinal studies are
needed to investigate the effects of dietary interventions
and supplements in children with ASD. Future guidelines
should be more explicit concerning dietary interventions
and supplementations for this complex and impairing
condition.

Review Limitations
The number of studies investigating dietary
interventions and supplementation in children with ASD
is variable in their designs and results. ASD symptoms
were not clearly described in some of these studies.
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